Baselake Partners, LP

Holdings History for Neuphoria Therapeutics Inc. - Common Stock, $0.00001 par value per share (NEUP)

Symbol: NEUP on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Shares Owned: 222,222 shares
Security Ownership %: 4.1%

Baselake Partners, LP ownership in Neuphoria Therapeutics Inc. Common Stock, $0.00001 par value per share (NEUP)

06 Feb 2026 - Baselake Partners, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 222,222 shares of Neuphoria Therapeutics Inc. Common Stock, $0.00001 par value per share (NEUP). This represents 4.1% ownership of the company. In their previous filing dated 31 Oct 2025, Baselake Partners, LP had reported owning 222,222 shares, indicating a new holding.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Baselake Partners, LP	4.1%	-59%	$862,110	222,222	0		$3.88	13G/A	31 Dec 2025	06 Feb 2026, 16:29
Baselake Partners, LP	9.4%		$2,635,553	222,222			$11.86	13G	27 Oct 2025	31 Oct 2025, 16:31